← All companies on record
Healthcare

Abbott India Limited

ABBOTINDIA · NIFTYPHARMA
26,170.00
+0.38%
close, 16 Oct 2026
Traded value
₹10 Cr
#151 in the basket
Volume
3,831
Shares
Session range
25,910.00–26,230.00
Low to high
Open
26,070.00
First trade
Closing price, last 24 sessions collected25,550.00 – 27,270.00

Where this sits in the session

Measured against the 153 priced constituents the platform tracks, and against the 22 of them in Healthcare.

Share of basket turnover
0.02%
₹10 Cr of the session, ranked #151 of 153
Share of sector turnover
0.3%
#22 of 22 in Healthcare
Against the sector
+0.89%
This name +0.38% against a −0.51% sector average
Sector breadth
7 / 15
Advanced against declined, of 22 traded

Most traded in Healthcare this session

Other constituents in the same sector, ranked by traded value for this session, with their close, change and traded value.
CompanyCloseChangeTraded value
Divi's Laboratories LimitedDIVISLAB9,144.50+1.27%₹712 Cr
Apollo Hospitals Enterprise LimitedAPOLLOHOSP7,890.00+0.01%₹432 Cr
Max Healthcare Institute LimitedMAXHEALTH846.00−1.40%₹341 Cr
Laurus Labs LimitedLAURUSLABS2,060.10+2.06%₹331 Cr
Sun Pharmaceutical Industries LimitedSUNPHARMA1,758.80−0.29%₹268 Cr
Mankind Pharma LimitedMANKIND2,275.50−3.07%₹202 Cr
Zydus Lifesciences LimitedZYDUSLIFE1,123.00−1.51%₹180 Cr
Dr. Reddy's Laboratories LimitedDRREDDY1,233.00+1.17%₹155 Cr

Traded value is closing price multiplied by reported volume. Shares are measured against the 153 deduplicated constituents of the nine tracked indices, not against the whole exchange. The sector average is unweighted, so a small member moves it as much as a large one; the member count sits beside it. Every sector ↗

Disclosed transactions

No bulk or block transactions disclosed in this security across the sessions collected.

Substantial acquisitions

No SEBI SAST filing has been recorded against this company since collection began.

Prices sourced from Yahoo Finance ↗. Transactions and SAST filings sourced from the National Stock Exchange ↗. No content on this page constitutes a recommendation, and no entry is inferred. Every line records a disclosure made by a publishing authority.